Physician profile
Amanda Chavez
NPI 1407201221
$1,329.64
in general payments reported to CMS, 2019-2025
20 companies · $52.88 in 2025
The $52.88 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $372 · 2022: $335 · 2023: $355 · 2024: $62.59 · 2025: $52.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $250.57 | 2022-2023 | Azstarys |
| Tris Pharma INC | $164.99 | 2020-2023 | Dyanavel Xr |
| Cranial Technologies, INC | $164.03 | 2020-2023 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $136.11 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $112.19 | 2020-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $90.35 | 2022-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $78.15 | 2021-2023 | |
| Pfizer INC. | $52.53 | 2022-2024 | |
| Biomarin Pharmaceutical INC. | $31.31 | 2025 | Voxzogo 1.2mg |
| Phadia US INC. | $31.26 | 2021 | |
| Neos Therapeutics, LP | $30.89 | 2020-2021 | |
| Glaxosmithkline, LLC. | $27.32 | 2023 | Bexsero, Pediarix |
| Genentech USA, INC. | $26.84 | 2020-2021 | |
| Verrica Pharmaceuticals INC. | $22.47 | 2023 | Ycanth |
| Alexion Pharmaceuticals, INC. | $22.44 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $21.57 | 2025 | Neffy |
| Nestle Healthcare Nutrition INC. | $21.47 | 2021 | |
| Sobi, INC | $18.72 | 2021 | |
| Supernus Pharmaceuticals, INC. | $13.89 | 2021 | |
| Elevate Oral Care | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.